此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effect of Transversus Abdominis Plane (TAP) Block Using Magnesium Sulfate Added to Dexamethasone on Quality of Recovery and Chronic Post Operative Pain Following Open Abdominal Cancer Surgery.

2026年11月4日 更新者:Madona M.NOMAN、Assiut University

Effect of Magnesium Sulfate Added to Dexamethasone-Augmented Ultrasound-Guided Transversus Abdominis Plane (TAP) Block on Early Quality of Recovery and Chronic Post Operative Pain Following Open Abdominal Cancer Surgery: A Prospective Randomized Double-Blind Controlled Trial

This prospective, randomized, double-blind, controlled clinical trial is designed to evaluate whether adding magnesium sulfate to a dexamethasone-augmented, ultrasound-guided transversus abdominis plane (TAP) block improves early postoperative recovery and analgesia in adult patients undergoing open abdominal cancer surgery.

A total of 72 participants will be allocated into two groups. Both groups will receive a standard TAP block using bupivacaine and dexamethasone, while the intervention group will additionally receive magnesium sulfate.

The primary outcome of the study is the early quality of recovery assessed at 24 hours postoperatively. Secondary outcomes include postoperative pain scores, total opioid consumption, time to first rescue analgesia, the incidence of postoperative nausea and vomiting, patient satisfaction, block-related complications, intraoperative opioid requirements, hemodynamic parameters, and the incidence of chronic postoperative pain assessed through six months of follow-up.

研究概览

研究类型

介入性

注册 (估计的)

72

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

      • Asyut、埃及
        • South Egypt Cancer Institute, Assiut University, Egypt
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 70年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • •Age 18-70 years.

    • ASA physical status I-III.
    • Scheduled for elective abdominal cancer surgery.
    • Able to understand the study protocol and complete the QoR-15 questionnaire. Provided written informed consent

Exclusion Criteria:

  • • Patient refusal.

    • Allergy to local anesthetics, dexamethasone, magnesium sulfate, or study medications.
    • Coagulopathy or anticoagulant therapy.
    • Local infection at the injection site.
    • Severe hepatic or renal impairment.
    • Neuromuscular disorders.
    • Chronic opioid use or chronic pain syndromes.
    • Pregnancy or lactation in females .
    • BMI >35 kg/m².
    • Cognitive impairment or inability to communicate effectively.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:支持治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:四人间

武器和干预

参与者组/臂
干预/治疗
有源比较器:Group D

Patients will receive bilateral ultrasound-guided TAP block using:20ml of 0.5% Bupivacaine 100mg mixed with 8mg dexamethasone (2ml) and diluted to 40ml with normal saline (18ml),20ml per side.

Patients will receive bilateral ultrasound-guided TAP block using:20ml of 0.5% Bupivacaine 100mg total volume 40ml ,20ml volume per side in both groups.

Dexamethasone 8 mg will be administered as an adjunct to TAP block in both groups

实验性的:Group DM

Patients will receive bilateral ultrasound-guided TAP block using:20ml of 0.5% Bupivacaine 100mg mixed with 8mg dexamethasone (2ml),250mg magnesium sulfate (2.5ml) and diluted to 40ml with normal saline (15.5ml),20ml per side

Patients will receive bilateral ultrasound-guided TAP block using:20ml of 0.5% Bupivacaine 100mg total volume 40ml ,20ml volume per side in both groups.

Dexamethasone 8 mg will be administered as an adjunct to TAP block in both groups

Magnesium sulfate 250 mg will be administered as an adjunct to TAP block in DM group only

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Quality of Recovery-15 (QoR-15) score
大体时间:24 hours postoperatively

The Quality of Recovery-15 questionnaire will be used to assess the quality of postoperative recovery 24 hours after surgery, evaluating five dimensions: physical comfort, emotional state, psychological support, physical independence, and pain, resulting in a total score ranging from 0 to 150 (higher scores indicate better recovery).

24 hours postoperatively

次要结果测量

结果测量
措施说明
大体时间
Total Postoperative Opioid Consumption
大体时间:During the first 24 hours postoperatively

Measuring the total morphine consumption required by the patient as rescue analgesia.

During the first 24 hours postoperatively
Time to First Request for Rescue Analgesia
大体时间:Within the first 24 hours postoperatively

Recording the duration from the end of surgery until the patient first requests rescue analgesia (when Visual Analogue Scale (VAS)is 4 or more).

Within the first 24 hours postoperatively
Mean Arterial Pressure (MAP)
大体时间:At baseline, after block, every 15 minutes intraoperatively, and at the end of surgery (extubation period).

Assessing Mean Arterial Pressure (MAP) values

At baseline, after block, every 15 minutes intraoperatively, and at the end of surgery (extubation period).
Chronic Postoperative Pain
大体时间:Through 6 months postoperatively

Assessing the presence or absence of chronic postoperative pain and its intensity using the Visual Analogue Scale (VAS)ranging from 0 (no pain) to 10 (worst imaginable pain)minimum value of 0, maximum value of 10, where higher scores mean a worse outcome.

Through 6 months postoperatively
Postoperative Pain Intensity
大体时间:At arrival to Post- Anesthesia Care Unit (PACU) (0 hour), 2, 4, 6, 12, and 24 hours postoperatively.]

Evaluating postoperative pain intensity using the Visual Analogue Scale (VAS) ranging from 0 (no pain) to 10 (worst imaginable pain).

At arrival to Post- Anesthesia Care Unit (PACU) (0 hour), 2, 4, 6, 12, and 24 hours postoperatively.]
Patient Satisfaction
大体时间:At 24 hours postoperatively

Evaluating patient satisfaction with postoperative pain management using a 5-point Likert scale (ranging from very dissatisfied to very satisfied)(minimum value of 1, maximum value of 5, where higher scores mean a better outcome).

At 24 hours postoperatively
TAP Block-Related Complications and Adverse Effects
大体时间:Intraoperatively and throughout the 24-hour postoperative period

Evaluating the overall incidence of any block-related complications or adverse events (including block failure, local anesthetic systemic toxicity, hematoma, infection, pneumothorax, nerve injury, or magnesium-related side effects), reported as the percentage of affected patients out of the total study population

Intraoperatively and throughout the 24-hour postoperative period
Intraoperative Fentanyl Requirements
大体时间:Intraoperatively (during the surgical procedure)

Measuring the total intraoperative consumption of fentanyl.

Intraoperatively (during the surgical procedure)
Postoperative Nausea
大体时间:During the first 24 hours postoperatively

Recording the incidence of postoperative nausea episodes

During the first 24 hours postoperatively
Postoperative Vomiting
大体时间:During the first 24 hours postoperatively

Recording the incidence of postoperative vomiting episodes.

During the first 24 hours postoperatively
Heart rate
大体时间:At baseline, after block, every 15 minutes intraoperatively, and at the end of surgery (extubation period)

Assessing heart rate values.

At baseline, after block, every 15 minutes intraoperatively, and at the end of surgery (extubation period)
Oxygen Saturation (SpO2)
大体时间:At baseline, after block, every 15 minutes intraoperatively, and at the end of surgery (extubation period)

Assessing peripheral oxygen saturation levels.

At baseline, after block, every 15 minutes intraoperatively, and at the end of surgery (extubation period)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Madona M Noman, MD、Assiut University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年12月1日

初级完成 (估计的)

2028年12月1日

研究完成 (估计的)

2028年12月1日

研究注册日期

首次提交

2026年11月4日

首先提交符合 QC 标准的

2026年11月4日

首次发布 (实际的)

2026年11月10日

研究记录更新

最后更新发布 (实际的)

2026年11月10日

上次提交的符合 QC 标准的更新

2026年11月4日

最后验证

2026年11月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅